• Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
  • Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
  • Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
  • Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
  • Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
  • Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Solid
Purity: >99%
Samples:
US$ 100/kg 1 kg(Min.Order)
| Request Sample
Customization:
Gold Member Since 2021

Suppliers with verified business licenses

Hubei, China
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Experienced Team
The supplier has 8 foreign trading staff(s) and 8 staff(s) with over 6 years of overseas trading experience
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
to see all verified strength labels (12)
  • Overview
  • Product Parameters
  • Product Description
  • Detailed Photos
  • Company Profile
  • Certifications
  • Exhibition
  • Packaging & Shipping
Overview

Basic Info.

Model NO.
Lifitegrast CAS 1025967-78-5
Transport Package
Bag, Drum
Specification
99% min
Trademark
Hanways
Origin
China
Production Capacity
5 Tons Per Month

Product Description

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
Palbociclib hydrochloride CAS 827022-32-2 for Breast cancer treatment
 
Product Parameters

Name

Lifitegrast

CAS

1025967-78-5

MF

C29H24Cl2N2O7S

MW

615.48

EINECS

813-044-8

Appearance

white Powder

Categories

API;Pharmaceuticals.

Uses

Lifitegrast is used for the treatment of signs and symptons of dry eye diseases. It also Inhibites corneal inflammation that is capable of causing pains, blurred vision and ocular discomfort in sufferer.

Product Description
 
Lifitegrast is used for the treatment of signs and symptons of dry eye diseases. It also Inhibites corneal inflammation that is capable of causing pains, blurred vision and ocular discomfort in sufferer.
Detailed Photos

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5

Company Profile

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5

Certifications

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5

Exhibition

 

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5
Packaging & Shipping

 

Eye Diseases Pharmaceutical Intermediate Lifitegrast CAS 1025967-78-5

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Gold Member Since 2021

Suppliers with verified business licenses

Trading Company
Number of Employees
9
Year of Establishment
2013-08-23